Koshinski Asset Management
WGS icon

Koshinski Asset Management’s GeneDx Holdings WGS Stock Holding History

Koshinski Asset Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6
Closed -$614 – 1956
2022
Q1 		$614 Hold
6
– – ﹤0.01% 2100
2021
Q4 		$892 Hold
6
– – ﹤0.01% 2083
2021
Q3 		$1.52K Buy
+6
New +$2.06K ﹤0.01% 2067

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Koshinski Asset Management's WGS Position: Q2 2022 in Review

Koshinski Asset Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 6 shares — an estimated $614 sold.

Koshinski Asset Management first reported a position in WGS in Q3 2021 and held it in 3 quarters. The position peaked at $1.52K in Q3 2021. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

  • Koshinski Asset Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 6 GeneDx Holdings shares in Q2 2022, an estimated $614.
  • Koshinski Asset Management first reported a position in GeneDx Holdings in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's GeneDx Holdings position peaked at $1.52K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.